Skip to content

IGF-LR3

Also called IGF-1 LR3 / Long R3 IGF-1

Modified IGF-1 that resists binding proteins, so it stays active far longer than native IGF-1.

  • TypePeptide
  • FormInjectable
  • Researched forGH & Growth
IGF-LR3 by AminoWell USA
Photo: AminoWell USA

Where to get IGF-LR3

AminoWell USA
Injectable
Code CAMERON

Create a free account (21+), then use code CAMERON. The only form sold. Research compound, not approved for human use.

Shop injectable at AminoWell USA

The short version

  • Why people research itAnabolism, muscle hyperplasia and recovery (advanced tool).
  • What the evidence isNo randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
  • What to watchShaking, sweating or confusion.

How IGF-LR3 works

Modified IGF-1 that resists binding proteins, so it stays active far longer than native IGF-1 — drives anabolism and hyperplasia.

The name says what was done to the molecule, and the market has read it as something else. Long R3 IGF-I is human IGF-I with two changes: arginine substituted at residue 3 in place of the native glutamate, and a 13-residue extension added to the N-terminus.

What the Arg3 substitution actually does. The N-terminal region of IGF-I contains the contact residues for the IGF-binding proteins, and Glu3 is one of them. Replace it with arginine — swapping a negative side chain for a positive one at a contact point — and the binding-protein interaction is destroyed while the receptor-binding face, which is elsewhere on the molecule, is left intact.

  • Injectable

On the goal map: GH / IGF-1 axis (Build muscle & strength)

Research on IGF-LR35 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Human clinical evidence

  • No randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.

    No completed human trial

Correlative data

  • Recombinant IGF-1 itself (mecasermin) IS an approved human drug for severe primary IGF-1 deficiency, and its label is the most useful document here.

  • LR3 is a modified analog with far lower binding-protein affinity, so more of it circulates free and active. That does not make it last longer: in rats it is cleared from the circulation faster than native IGF-1, and its half-life in people has never been measured. Nothing about the human data on mecasermin transfers cleanly to it except the direction of the risk.

How the mechanism reads

  • The Long-Arg3 modification prevents IGF-binding-protein capture, so the peptide stays free instead of parked in the binding-protein reservoir. That is the whole design and it predicts both effects: much greater anabolic signaling per unit, and much greater hypoglycemia risk than native IGF-1.

    Mechanistic
  • Sustained IGF-1 receptor activation is also the mechanism behind the long-term concern nobody can resolve — IGF-1 signaling promotes proliferation indiscriminately, which is useful in muscle and unwelcome anywhere with an undiagnosed problem.

    Mechanistic

Sources

IGF-LR3 safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Any cancer or precancerous lesion, since sustained IGF-1 receptor activation is mitogenic.
  • Diabetes or low blood sugar on glucose-lowering drugs.
  • Heavy fasting or endurance training with low fuel.
  • Eye disease from diabetes, where IGF-1 signaling can worsen new vessel growth.
  • Pregnancy or under 18, with no human safety record at all.

What’s expected

  • Longer action than native IGF-1 because it evades binding proteins.
  • Hypoglycemia risk from insulin-like action.
  • Everything else is extrapolated from rodent work.

Watch for

  • Shaking, sweating or confusion.
  • Rapid growth of a mole or lump.
  • Swelling of hands and face.

Labs that tell you it’s working

  • IGF-1: may read low or odd, because the analog does not bind carrier proteins like the native peptide.
  • Insulin (Fasting): suppressed endogenous insulin tells you the signal landed.
  • Fructosamine: reads glucose swings over the past few weeks.
  • Comprehensive Metabolic Panel: fasting glucose and liver enzymes.

Long R3 IGF-1 analog that resists IGFBP binding for prolonged potency; no human trial, so profile is inferred from IGF-1 receptor biology. PMID 7561636 PMID 1371669

Bloodwork to runHow you would know it is working: 7 tests in one order, code CAMERON

IGF-LR3 FAQ4 common questions

Is IGF-LR3 approved for human use?
No. IGF-LR3 is a research compound. No completed randomized human trial has given it yet.
What is IGF-LR3 researched for?
Anabolism, muscle hyperplasia and recovery (advanced tool).
Which labs show whether it's doing anything?
IGF-1; Insulin; Fructosamine; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for IGF-LR3: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what IGF-LR3 is. Skool covers how it is run.

Free on this page

What IGF-LR3 is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What IGF-LR3 is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The IGF-LR3 lesson: the protocol, step by step, with Cam's video
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool